Harvard Bioscience, Inc. (HBIO) Key Statistics & Financial Ratios

Harvard Bioscience, Inc. (HBIO) — Price $7.97 — Healthcare — Medical - Instruments & Supplies — NASDAQ

Latest reported results:

Key statistics dashboard for Harvard Bioscience, Inc. (HBIO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.

Stock Data

Price$7.97
Market Cap$36M
Enterprise Value$73.6M
Beta1.50
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-3.44
Price / Book4.88
P/S0.41
EV/EBITDA-78.43
EV/Sales0.84
EV/FCF-52.16
P/FCF-25.55
Earnings Yield-28.86%
FCF Yield-3.93%
Dividend Yield0.00%

Profitability

Gross Margin58.16%
EBIT Margin-8.15%
EBITDA Margin-1.07%
Operating Margin1.17%
Net Margin-11.86%
Return on Equity-92.01%
Return on Assets-13.65%
Return on Invested Capital1.91%
Return on Capital Employed1.99%

Financial Health

Current Ratio1.87
Quick Ratio0.98
Cash Ratio0.26
Debt / Equity5.96
Debt / Assets57.95%
Net Debt / EBITDA-40.15
Interest Coverage0.30
Piotroski F-Score4
Altman Z-Score-2.04

Per-Share Data

Revenue per share19.40
Book Value per share1.64
Cash per share1.44
FCF per share-0.31
Tangible Book Value per share-1.80
Dividend per share0.00

Analyst Consensus

Strong Buy0
Buy4
Hold1
Sell0
Strong Sell0
Total analysts5
Avg rating (1-5)0.80

Related companies: CLGN · COSM · FEMY · NCNA · NXGL · NXL · RVP

Explore sector: Healthcare · Medical - Instruments & Supplies

More sections of HBIO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks